Skip to main navigation Skip to search Skip to main content

The value of hepatic resection in metastasic renal cancer in the Era of Tyrosinkinase Inhibitor Therapy.

  • Hans-Michael Hau* (First author)
  • , F Thalmann
  • , C Lübbert
  • , MH Morgul
  • , M Schmelzle
  • , G Atanasov
  • , C Benzing
  • , U Lange
  • , R Ascherl
  • , R Ganzer
  • , D Uhlmann
  • , HM Tautenhahn
  • , G Wiltberger
  • , M Bartels
  • *Corresponding author for this work

    Research output: Contribution to journalResearch article

    5 Citations (Web of Science)
    Original languageEnglish
    JournalBMC Surgery
    DOIs
    Publication statusPublished - 2016

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Branches of science

    • 302 Clinical Medicine

    Cite this